<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Sci</journal-id><journal-id journal-id-type="iso-abbrev">Vet Sci</journal-id><journal-id journal-id-type="publisher-id">vetsci</journal-id><journal-title-group><journal-title>Veterinary Sciences</journal-title></journal-title-group><issn pub-type="epub">2306-7381</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39728947</article-id><article-id pub-id-type="pmc">PMC11680352</article-id>
<article-id pub-id-type="doi">10.3390/vetsci11120607</article-id><article-id pub-id-type="publisher-id">vetsci-11-00607</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The Effect of Meloxicam on Inflammatory Response and Oxidative Stress Induced by <italic toggle="yes">Klebsiella pneumoniae</italic> in Bovine Mammary Epithelial Cells</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Kangjun</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-vetsci-11-00607" ref-type="aff">1</xref><xref rid="af2-vetsci-11-00607" ref-type="aff">2</xref><xref rid="af3-vetsci-11-00607" ref-type="aff">3</xref><xref rid="fn1-vetsci-11-00607" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Qiu</surname><given-names>Shangfei</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-vetsci-11-00607" ref-type="aff">1</xref><xref rid="af2-vetsci-11-00607" ref-type="aff">2</xref><xref rid="af3-vetsci-11-00607" ref-type="aff">3</xref><xref rid="fn1-vetsci-11-00607" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Fang</surname><given-names>Li</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><xref rid="af4-vetsci-11-00607" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9606-5105</contrib-id><name><surname>Cui</surname><given-names>Luying</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-vetsci-11-00607" ref-type="aff">1</xref><xref rid="af2-vetsci-11-00607" ref-type="aff">2</xref><xref rid="af3-vetsci-11-00607" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Dong</surname><given-names>Junsheng</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="af1-vetsci-11-00607" ref-type="aff">1</xref><xref rid="af2-vetsci-11-00607" ref-type="aff">2</xref><xref rid="af3-vetsci-11-00607" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Long</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><xref rid="af1-vetsci-11-00607" ref-type="aff">1</xref><xref rid="af2-vetsci-11-00607" ref-type="aff">2</xref><xref rid="af3-vetsci-11-00607" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6547-9417</contrib-id><name><surname>Meng</surname><given-names>Xia</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-vetsci-11-00607" ref-type="aff">1</xref><xref rid="af2-vetsci-11-00607" ref-type="aff">2</xref><xref rid="af3-vetsci-11-00607" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jianji</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-vetsci-11-00607" ref-type="aff">1</xref><xref rid="af2-vetsci-11-00607" ref-type="aff">2</xref><xref rid="af3-vetsci-11-00607" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Heng</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-vetsci-11-00607" ref-type="aff">1</xref><xref rid="af2-vetsci-11-00607" ref-type="aff">2</xref><xref rid="af3-vetsci-11-00607" ref-type="aff">3</xref><xref rid="c1-vetsci-11-00607" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Pedersen</surname><given-names>Karl</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vetsci-11-00607"><label>1</label>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China; <email>kangjunliu@yzu.edu.cn</email> (K.L.); <email>qiushangfei1@163.com</email> (S.Q.); <email>lycui@yzu.edu.cn</email> (L.C.); <email>junsheng@yzu.edu.cn</email> (J.D.); <email>yzdxgl@yzu.edu.cn</email> (L.G.); <email>mengxia@yzu.edu.cn</email> (X.M.); <email>jjli@yzu.edu.cn</email> (J.L.)</aff><aff id="af2-vetsci-11-00607"><label>2</label>International Research Laboratory of Prevention and Control of Important Animal Infectious Diseases and Zoonotic Diseases of Jiangsu Higher Education Institutions, Yangzhou 225009, China</aff><aff id="af3-vetsci-11-00607"><label>3</label>Joint International Research Laboratory of Agriculture and Agri-Product Safety of the Ministry of Education, Yangzhou 225000, China</aff><aff id="af4-vetsci-11-00607"><label>4</label>School of Veterinary Medicine, Jiangsu Agri-Animal Husbandry Vocational College, Taizhou 225300, China; <email>2023010549@jsahvc.edu.cn</email></aff><author-notes><corresp id="c1-vetsci-11-00607"><label>*</label>Correspondence: <email>wh@yzu.edu.cn</email></corresp><fn id="fn1-vetsci-11-00607"><label>&#x02020;</label><p>These authors contributed equally to the work.</p></fn></author-notes><pub-date pub-type="epub"><day>29</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>11</volume><issue>12</issue><elocation-id>607</elocation-id><history><date date-type="received"><day>22</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>20</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>27</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract abstract-type="plain-language-summary"><title>Simple Summary</title><p>Meloxicam in combination with antibiotics therapy has showed promising effects in clinical mastitis. The direct effects of MEL on bovine mammary epithelial cells are still not fully elucidated. Moreover, the effectiveness of meloxicam on the inflammatory response and oxidative stress induced by <italic toggle="yes">K. pneumoniae</italic> are also unclear. This study investigates the effects of meloxicam on bovine mammary epithelial cells in response to <italic toggle="yes">K. pneumoniae</italic> infection, with a focus on inflammatory response and oxidative stress. Primary bovine mammary epithelial cells were infected with <italic toggle="yes">K. pneumoniae</italic> in the presence or absence of plasma maintenance concentration of meloxicam (0.5 and 5 &#x003bc;M). At these concentrations, meloxicam was able to inhibit the mRNA expression of pro-inflammatory genes and relieve oxidative stress through the increased activity of superoxide dismutase and catalase and the level of total antioxidant capacity. The mechanisms by which meloxicam mitigated the inflammatory response and oxidative stress were partially attributed to inhibiting the nuclear transcription factor-kappa B signaling pathway and improving the activation of the nuclear factor erythroid 2-related factors signaling pathway.</p></abstract><abstract><title>Abstract</title><p><italic toggle="yes">Klebsiella pneumoniae</italic> (<italic toggle="yes">K. pneumoniae</italic>) is a significant pathogen associated with clinical mastitis in cattle. Anti-inflammatory drugs are necessary to alleviate pain and inflammation during clinical mastitis. Among many drugs, meloxicam (MEL) has been widely used in clinical mastitis because of its excellent inhibitory effect on the cyclooxygenase-2 (COX-2) enzyme. However, the effectiveness of MEL on the inflammatory response and oxidative stress induced by <italic toggle="yes">K. pneumoniae</italic> are unclear. In the present study, primary BMECs were infected with <italic toggle="yes">K. pneumoniae</italic> in the presence or absence of plasma maintenance concentration of MEL (0.5 and 5 &#x003bc;M). Following 1 or 3 h of combined treatment with <italic toggle="yes">K. pneumoniae</italic> and MEL, BMECs were gathered to assess the related indicators. The results showed that MEL at plasma maintenance concentrations exerted no influence on the viability of uninfected BMECs and also had no impact on bacterial load in BMECs. At these concentrations, MEL was able to inhibit the mRNA expression of COX-2, Interleukin (IL)-1&#x003b2;, Tumor necrosis factor &#x003b1; (TNF-&#x003b1;), and IL-6 while simultaneously elevating the mRNA levels of IL-8 in <italic toggle="yes">K. pneumoniae</italic>-infected BMECs. MEL had clear effects on relieving oxidative stress by increasing the activity of superoxide dismutase (SOD) and catalase (CAT) and the level of total antioxidant capacity (T-AOC). The mechanisms by which MEL mitigated the inflammatory response and oxidative stress were partially attributed to inhibition of the nuclear transcription factor-kappa B (NF-&#x003ba;B) signaling pathway and improvement of the activation of the nuclear factor erythroid 2-related factors (Nrf2) signaling pathway. To conclude, the results manifested that MEL at plasma maintenance concentrations protected BMECs from inflammatory and oxidative damage induced by <italic toggle="yes">K. pneumoniae</italic>.</p></abstract><kwd-group><kwd><italic toggle="yes">K. pneumoniae</italic></kwd><kwd>meloxicam</kwd><kwd>infection</kwd><kwd>anti-inflammatory</kwd><kwd>antioxidant</kwd></kwd-group><funding-group><award-group><funding-source>National Key R&#x00026;D Program of China</funding-source><award-id>2023YFD1801100</award-id></award-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>32273070</award-id></award-group><award-group><funding-source>Basic Science in Universities in Jiangsu Province</funding-source><award-id>24KJB230008</award-id></award-group><award-group><funding-source>Qing Lan Project of Yangzhou University, the Jiangsu Postgraduate Research and Innovation Plan</funding-source><award-id>KYCX23_3604</award-id></award-group><award-group><funding-source>Earmarked Fund for Jiangsu Agricultural Industry Technology System</funding-source><award-id>JATS [2023] 456</award-id></award-group><award-group><funding-source>333 High-level Talent Training Project of Jiangsu Province (CN)</funding-source></award-group><award-group><funding-source>International Research Laboratory of Prevention and Control of Important Animal Infectious Diseases and Zoonotic Diseases of Jiangsu Higher Education Institutions</funding-source><award-id>8</award-id></award-group><award-group><funding-source>Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)</funding-source></award-group><award-group><funding-source>111 Project</funding-source><award-id>D18007</award-id></award-group><funding-statement>The research was funded by the National Key R&#x00026;D Program of China (No. 2023YFD1801100), the National Natural Science Foundation of China (No. 32273070), Basic Science in Universities in Jiangsu Province (No. 24KJB230008), the Qing Lan Project of Yangzhou University, the Jiangsu Postgraduate Research and Innovation Plan (KYCX23_3604), the Earmarked Fund for Jiangsu Agricultural Industry Technology System (No. JATS [2023] 456), 333 High-level Talent Training Project of Jiangsu Province (CN), International Research Laboratory of Prevention and Control of Important Animal Infectious Diseases and Zoonotic Diseases of Jiangsu Higher Education Institutions (No. 8), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the 111 Project (No. D18007).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vetsci-11-00607"><title>1. Introduction</title><p>Bovine mastitis leads to considerable economic losses in the dairy industry and impacts animal welfare [<xref rid="B1-vetsci-11-00607" ref-type="bibr">1</xref>]. With the widespread implementation of mastitis control programs, environmental pathogens such as <italic toggle="yes">Klebsiella</italic> spp., <italic toggle="yes">Escherichia coli</italic> (<italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic>), and <italic toggle="yes">streptococci</italic> have become the most common causes of clinical mastitis [<xref rid="B2-vetsci-11-00607" ref-type="bibr">2</xref>,<xref rid="B3-vetsci-11-00607" ref-type="bibr">3</xref>]. <italic toggle="yes">K. pneumoniae</italic> is well recognized as a major environmental pathogen [<xref rid="B2-vetsci-11-00607" ref-type="bibr">2</xref>,<xref rid="B4-vetsci-11-00607" ref-type="bibr">4</xref>]. Currently, mastitis caused by <italic toggle="yes">K. pneumoniae</italic> is particularly problematic due to limited antimicrobial efficacy, poor bacteriological cure rate, and rapid progression to toxic shock [<xref rid="B2-vetsci-11-00607" ref-type="bibr">2</xref>,<xref rid="B5-vetsci-11-00607" ref-type="bibr">5</xref>,<xref rid="B6-vetsci-11-00607" ref-type="bibr">6</xref>]. In dairy cows, <italic toggle="yes">K. pneumoniae</italic> infection is prone to severe clinical mastitis with a prolonged and massive inflammatory response [<xref rid="B7-vetsci-11-00607" ref-type="bibr">7</xref>]. Intramammary infection with <italic toggle="yes">K. pneumoniae</italic> could lead to epithelial cell death, which prevents cows from returning to their pre-disease levels of milk production [<xref rid="B8-vetsci-11-00607" ref-type="bibr">8</xref>].</p><p>Giving the pain and inflammation during mastitis, nonsteroidal anti-inflammatory drugs (NSAIDs) are recommended to relieve the local and systemic clinical signs, thereby promoting the recovery of mammary normal physiology function. MEL, an NSAID, has been licensed for treating the pain and inflammation in clinical mastitis [<xref rid="B9-vetsci-11-00607" ref-type="bibr">9</xref>]. Compared with other nonspecific COX inhibitors, MEL not only has similar or better anti-inflammatory effects, but also has fewer adverse gastrointestinal effects [<xref rid="B10-vetsci-11-00607" ref-type="bibr">10</xref>]. MEL acts primarily through the selective inhibition of COX-2. COX-2 is one of the two isoforms of cyclooxygenase and converts arachidonic acid into prostaglandins, which leads to inflammatory reactions and tissue damage [<xref rid="B11-vetsci-11-00607" ref-type="bibr">11</xref>]. The content of COX-2 is extremely low in normal tissues, and its expression level can be significantly elevated when cells are stimulated by cytokines at the site of inflammation [<xref rid="B12-vetsci-11-00607" ref-type="bibr">12</xref>].</p><p>BMECs acts as sentinels of the mammary gland and have a quick reaction capacity to bacterial infection [<xref rid="B13-vetsci-11-00607" ref-type="bibr">13</xref>]. After pathogen infection, pattern-recognition receptors located on a wide array of cell types such as BMECs detect pathogen-associated molecular patterns, thereby initiating innate immunity [<xref rid="B14-vetsci-11-00607" ref-type="bibr">14</xref>]. In this process, NF-&#x003ba;B is promptly activated, thereby giving rise to the generation of cytokines. TNF-&#x003b1;, IL-1, and IL-8 are key pro-inflammatory cytokines inducing acute-phase response, fever, and recruitment of neutrophils [<xref rid="B15-vetsci-11-00607" ref-type="bibr">15</xref>,<xref rid="B16-vetsci-11-00607" ref-type="bibr">16</xref>]. In bovine mammary glands, the levels of pro-inflammatory cytokines like TNF-&#x003b1;, IL-1&#x003b2;, and IL-8 increased rapidly within 24 h following <italic toggle="yes">K. pneumoniae</italic> infection [<xref rid="B17-vetsci-11-00607" ref-type="bibr">17</xref>]. Our previous study also showed that <italic toggle="yes">K. pneumoniae</italic> was able to induce an inflammatory response by activating NF-&#x003ba;B in cultured BMECs [<xref rid="B18-vetsci-11-00607" ref-type="bibr">18</xref>].</p><p>Persistent infection with <italic toggle="yes">K. pneumoniae</italic> leads to ultrastructural damage in BMECs [<xref rid="B8-vetsci-11-00607" ref-type="bibr">8</xref>]. Mitochondria are often targeted by pathogens because of their role in energy metabolism and antimicrobial innate immunity [<xref rid="B19-vetsci-11-00607" ref-type="bibr">19</xref>]. In a recent study, it has demonstrated that <italic toggle="yes">K. pneumoniae</italic> infection results in mitochondrial damage and dysfunction in BMECs [<xref rid="B20-vetsci-11-00607" ref-type="bibr">20</xref>]. Mitochondria are a major source of reactive oxygen species (ROS), and abnormal mitochondrial function induces a large amount of ROS production. When ROS levels exceed the antioxidant capacity of the cells, it causes oxidative stress [<xref rid="B21-vetsci-11-00607" ref-type="bibr">21</xref>]. Usually, oxidative stress further exacerbates mitochondrial dysfunction, ultimately leading to cell damage and death.</p><p>In dairy cows with clinical mastitis, MEL in combination with antibiotics therapy was effective in reducing somatic cell counts and the risk of culling cows as well as improving the bacteriological cure [<xref rid="B22-vetsci-11-00607" ref-type="bibr">22</xref>,<xref rid="B23-vetsci-11-00607" ref-type="bibr">23</xref>]. Furthermore, meloxicam has showed promising effects in relieving pain, udder edema, and body temperature in endotoxin-induced clinical mastitis [<xref rid="B9-vetsci-11-00607" ref-type="bibr">9</xref>]. Although current studies have demonstrated the positive efficacy of MEL in the treatment of clinical mastitis, the direct effects of MEL on BMECs are still not fully elucidated. Further research is needed to determine whether MEL has effects on BMECs in response to <italic toggle="yes">K. pneumoniae</italic> infection.</p></sec><sec id="sec2-vetsci-11-00607"><title>2. Materials and Methods</title><sec id="sec2dot1-vetsci-11-00607"><title>2.1. Antibodies</title><p>The following primary antibodies were used: p65 (1:2000, Proteintech, Rosemont, IL, USA), COX-2 (1:1000, Wanleibio, Xi&#x02019;an, China), p-p65 (1:1000, Cell Signaling Technology, Danvers, MA, USA), &#x003b2;-actin (1:1000, Santa Cruz Biotechnology, Dallas, TX, USA), I&#x003ba;B&#x003b1; (1:1000, Cell Signaling Technology, Danvers, MA, USA), Lamin B1 (1:1000, Affinity, Shanghai, China), p-I&#x003ba;B&#x003b1; (1:1000, Cell Signaling Technology, Danvers, MA, USA), Nrf2 (1:1000, Proteintech, Rosemont, IL, USA), HO-1 (1:2000, Abcam, Cambridge, UK), NQO-1 (1:10,000, Abcam, Cambridge, UK), and Keap1 (1:2000, Proteintech, Rosemont, IL, USA).</p></sec><sec id="sec2dot2-vetsci-11-00607"><title>2.2. Culture of BMEC</title><p>Holstein dairy cows were provided by the farm of Yangzhou University. The experimental protocol was approved by the Animal Care and Ethics Committee of Yangzhou University (approval ID: 202205130). Clinically healthy mammary tissues were collected from lactating cows to prepare primary mammary epithelial cells as described by Wang et al. [<xref rid="B24-vetsci-11-00607" ref-type="bibr">24</xref>]. In brief, try to collect the acini from the mammary glands while avoiding connective tissue. The acini tissue was cut into mince and subsequently subjected to digestion using 0.25% type II collagenase (C6885, Sigma-Aldrich, St. Louis, MO, USA) at a temperature of 37 &#x000b0;C for a duration of 2 h. The digested tissue suspension was filtered sequentially through 20- and 80-mesh filters. Then, the tissue suspension was centrifuged and cultured with DMEM/F12 (D8900, Sigma-Aldrich, St. Louis, MO, USA) containing 10% fetal bovine serum (FBS, A3161002CC, Gibco, Newcastle, Australia), 2 mmol/L L-glutamine, 100 U/mL penicillin, and 100 ug/mL streptomycin in an incubator at 37 &#x000b0;C and 5% CO<sub>2</sub>. Purified epithelial cells could be obtained after two passages based on the differential sensitivity of epithelial cells and stromal cells to trypsin.</p></sec><sec id="sec2dot3-vetsci-11-00607"><title>2.3. Preparation of K. pneumoniae</title><p>The <italic toggle="yes">K. pneumoniae</italic> strain utilized in the present study was obtained from a milk sample of bovine mastitis [<xref rid="B25-vetsci-11-00607" ref-type="bibr">25</xref>]. Our previous study showed that this <italic toggle="yes">K. pneumoniae</italic> isolate was able to induce inflammatory response and inhibit autophagy in cultured immortalized BMECs [<xref rid="B18-vetsci-11-00607" ref-type="bibr">18</xref>]. <italic toggle="yes">K. pneumoniae</italic> were cultured in liquid Luria&#x02013;Bertani medium until the logarithmic growth phase at 37 &#x000b0;C. Bacterial precipitates were collected through centrifugation at 3000 rpm for a duration of 5 min, and then the PBS was used to resuspend bacterial precipitates. The above operation was repeated three times. Finally, the <italic toggle="yes">K. pneumoniae</italic> isolate was diluted with DMEM/F12.</p></sec><sec id="sec2dot4-vetsci-11-00607"><title>2.4. Cell Viability Analysis</title><p>BMECs were seeded into 96-well plates at a density of 1 &#x000d7; 10<sup>3</sup> per well and cultured in an incubator at 37 &#x000b0;C with 5% CO<sub>2</sub> until the cell density reached 80% confluence. The cells were washed three times with PBS and then incubated with different concentrations of MEL (M3935, Sigma-Aldrich, St. Louis, MO, USA) for 12 h. After washing with PBS, the cells were cultured with CCK-8 (A311-01, Vazyme, Nanjing, China) working solution for 2 h according to the instructions. Then, the absorbance was detected at a wavelength of 450 nm.</p></sec><sec id="sec2dot5-vetsci-11-00607"><title>2.5. Cell Infection and MEL Treatment</title><p>The ratio of <italic toggle="yes">K. pneumoniae</italic> to cells was defined as the multiplicity of infection (MOI). When the cells reached 80% confluence in a 6-well plate, the medium was changed to DMEM/F12 supplemented with 5% FBS but no antibiotics. Cells were first infected with <italic toggle="yes">K. pneumoniae</italic> at a MOI of 10 for 30 min, and then MEL was added to the cultures with a final concentration of 0.5 or 5 &#x003bc;&#x0039c;. After cells were treated with <italic toggle="yes">K. pneumoniae</italic> and MEL together for another 1 h or 3 h, the cells were collected for subsequent experiment. To investigate the effects of MEL on inflammatory response and oxidative stress induced by <italic toggle="yes">K. pneumoniae</italic> in BMECs, five groups were assigned: a negative control group (medium only), MEL control group (medium only containing 5 &#x003bc;M MEL), <italic toggle="yes">K. pneumoniae</italic>-infected group (cells were infected with <italic toggle="yes">K. pneumoniae</italic> as described above), and two <italic toggle="yes">K. pneumoniae</italic> + MEL (0.5 or 5 &#x003bc;M) groups (cells were treated with <italic toggle="yes">K. pneumoniae</italic> and MEL together for 1 h or 3 h).</p></sec><sec id="sec2dot6-vetsci-11-00607"><title>2.6. Western Blot Analysis</title><p>Total protein was extracted from BMECs on ice with RIPA buffer containing a mixture of protease and phosphatase inhibitors. The nuclear protein was extracted from BMECs according to the method in the instructions (P0027, Beyotime, Haimen, China). Protein concentrations were detected using a BCA kit (P0010, Beyotime, Haimen, China) and adjusted for the same concentration. Proteins were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred to a polyvinylidene difluoride membrane. The membranes were blocked through immersing in 5% skimmed milk for 1 h at room temperature and incubated with specific primary antibodies at 4 &#x000b0;C overnight. Subsequently, the membranes were incubated with HRP-conjugated goat anti-rabbit (#7074, Cell Signaling Technology, Danvers, MA, USA) or goat anti-mouse (Lot. 366, Medical &#x00026; Biological Laboratories, Tokyo, Japan) secondary antibody at room temperature for 1 h. Finally, the chemiluminescence ECL assay kit (E412-01, Vazyme, Nanjing, China) was used to detect immunoreactive protein bands. The gray scale of protein bands was quantified using Image J software (Image J 1.54).</p></sec><sec id="sec2dot7-vetsci-11-00607"><title>2.7. RNA Extraction and Real-Time Quantitative PCR</title><p>Total RNA was extracted from BMECs using TRIzol reagent (R401-01, Vazyme, Nanjing, China) and quantified by Nanodrop-2000 spectrophotometer. One microgram of total RNA was transcribed into cDNA using reverse transcription kit (R123-01, Vazyme, Nanjing, China). PCR was performed using SYBR qPCR Master Mix (Q311-02/03, Vazyme, Nanjing, China) according to the manufacturer&#x02019;s instructions on a PCR system. The primer sequences are shown in <xref rid="vetsci-11-00607-t001" ref-type="table">Table 1</xref>. The relative expression of IL-1&#x003b2;, IL-6, IL-8, TNF-&#x003b1;, and COX-2 were normalized to &#x003b2;-actin and calculated using the 2<sup>&#x02212;&#x00394;&#x00394;ct</sup> method as described previously [<xref rid="B26-vetsci-11-00607" ref-type="bibr">26</xref>].</p></sec><sec id="sec2dot8-vetsci-11-00607"><title>2.8. Detection of Bacterial Load</title><p>BMECs were seeded into 24-well plates to ascertain that they were at least 90% confluent. After infection with <italic toggle="yes">K. pneumoniae</italic> for 3 h in the presence of MEL, the cells were washed three times with PBS and then lysed with 0.3% Triton X-100 for 15 min. The lysate was collected and gradient diluted. The appropriate dilutions were inoculated onto LB agar plates, and the numbers of colonies were counted after incubation at 37 &#x000b0;C for 24 h. To investigate the effects of MEL on <italic toggle="yes">K. pneumoniae</italic> load in BMECs, three groups were assigned: <italic toggle="yes">K. pneumoniae</italic>-infected group (cells were infected with <italic toggle="yes">K. pneumoniae</italic> as described above) and <italic toggle="yes">K. pneumoniae</italic> + MEL (0.5 or 5 &#x003bc;M) groups (cells were treated with <italic toggle="yes">K. pneumoniae</italic> and MEL together for 3 h).</p></sec><sec id="sec2dot9-vetsci-11-00607"><title>2.9. Detection of Intracellular ROS</title><p>The ROS level was detected using a fluorescent probe DCFH-DA (S0033S, Beyotime, Haimen, China) after cells were treated with <italic toggle="yes">K. pneumoniae</italic> and MEL together for 3 h. The cells were collected and incubated with DCFH-DA (10 &#x003bc;M) for 20 min at 37 &#x000b0;C. Then, the fluorescence of DCF that represents ROS levels was detected using a flow cytometer at a wavelength of 488 nm.</p></sec><sec id="sec2dot10-vetsci-11-00607"><title>2.10. Detection of SOD, CAT, T-AOC, and Malondialdehyde (MDA)</title><p>The cells were collected from 6-well plates after infection with <italic toggle="yes">K. pneumoniae</italic> for 3 h in the presence of MEL. Cell lysate was obtained though sonication on ice followed by centrifugation at 4 &#x000b0;C. The activities of SOD and CAT and the levels of T-AOC and MDA were detected using commercial kits from Nanjing Jiancheng Bioengineering Institute (Nanjing, China).</p></sec><sec id="sec2dot11-vetsci-11-00607"><title>2.11. Immunofluorescence</title><p>Cells were seeded on cell slides and treated with <italic toggle="yes">K. pneumoniae</italic> and/or MEL in a 24-well plate. The cells were fixed with pre-cooled 4% paraformaldehyde for 15 min, and then underwent a permeabilization treatment with 0.3% Triton&#x000d7;100 at room temperature for 15 min. The permeabilized cells were blocked with 5% BSA at 37 &#x000b0;C for 1 h. To observe the nuclear accumulation of p65 protein, cells were incubated with anti-p65 (dilution ratio of 1:200) at 4 &#x000b0;C for 12 h. Subsequently, fluorescence-conjugated secondary antibody was added to the well and the 24-well plate was placed at 37 &#x000b0;C for 1 h in the dark. Ultimately, cell nuclei were stained with DAPI. The images were inspected and collected by means of a fluorescence microscope.</p></sec><sec id="sec2dot12-vetsci-11-00607"><title>2.12. Statistics</title><p>All assays were independently replicated at least three times to obtain experimental data. Data were shown as the means &#x000b1; standard error of means. Statistical analysis, including one-way ANOVA and the least significant differences test, were carried out through SPSS 21.0 software (IBM, New York, NY, USA). A <italic toggle="yes">p</italic> value less than 0.05 or 0.01 was considered significant between groups.</p></sec></sec><sec sec-type="results" id="sec3-vetsci-11-00607"><title>3. Results</title><sec id="sec3dot1-vetsci-11-00607"><title>3.1. Cell Viability and the Concentration of MEL</title><p>The effect of MEL on the BMECs&#x02019; viability was evaluated by CCK-8 assay. As shown in <xref rid="vetsci-11-00607-f001" ref-type="fig">Figure 1</xref>, MEL (0.5 and 5 &#x003bc;M) had no significant effect on the BMECs&#x02019; viability compared with the control group (<italic toggle="yes">p</italic> &#x0003e; 0.05). There was no significant difference between the different concentrations (0.5, 5, 10, 20, and 40 &#x003bc;M). Subcutaneous injection of MEL at 0.5 mg/kg body weight is a commonly used dose for adjunctive treatment of clinical mastitis [<xref rid="B9-vetsci-11-00607" ref-type="bibr">9</xref>,<xref rid="B22-vetsci-11-00607" ref-type="bibr">22</xref>,<xref rid="B27-vetsci-11-00607" ref-type="bibr">27</xref>]. The maximum plasma concentration of MEL was 3.47 &#x003bc;M and 4.78 &#x003bc;M after subcutaneous and oral (0.5 mg/kg body weight) administration, respectively, and the plasma concentration of MEL after 72 h was 0.28 &#x003bc;M and 1.42 &#x003bc;M, respectively [<xref rid="B28-vetsci-11-00607" ref-type="bibr">28</xref>]. Therefore, the concentrations of 0.5 and 5 &#x003bc;M were selected to explore the effects of MEL on oxidative stress and inflammatory response in BMECs.</p></sec><sec id="sec3dot2-vetsci-11-00607"><title>3.2. Bacterial Load</title><p>Bacterial load is an important part of bacterial pathogenesis. Therefore, the effect of MEL on the bacterial load was examined in <italic toggle="yes">K. pneumoniae</italic>-infected BMECs. The results indicated that MEL had no effect on <italic toggle="yes">K. pneumoniae</italic> load in BMECs (<italic toggle="yes">p</italic> &#x0003e; 0.05) (<xref rid="vetsci-11-00607-f002" ref-type="fig">Figure 2</xref>).</p></sec><sec id="sec3dot3-vetsci-11-00607"><title>3.3. MEL Inhibits the Production of COX-2</title><p>MEL is considered a preferred COX-2 inhibitor. First, the effects of MEL on COX-2 production in <italic toggle="yes">K. pneumoniae</italic>-infected BMECs were examined by qPCR and Western blot analysis. As depicted in <xref rid="vetsci-11-00607-f003" ref-type="fig">Figure 3</xref>, <italic toggle="yes">K. pneumoniae</italic> infection increased the mRNA and protein expression levels of COX-2 (<italic toggle="yes">p &#x0003c;</italic> 0.01) compared with the control group. MEL (5 &#x003bc;M) suppressed the mRNA expression levels of COX-2 induced by <italic toggle="yes">K. pneumoniae</italic> (<italic toggle="yes">p &#x0003c;</italic> 0.05) compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> alone. The increased protein level of COX-2 induced by <italic toggle="yes">K. pneumoniae</italic> was also inhibited by MEL treatment (<italic toggle="yes">p</italic> &#x0003c; 0.05 or <italic toggle="yes">p</italic> &#x0003c; 0.01). Moreover, MEL alone can suppress the protein level of COX-2 compared with the control group (<italic toggle="yes">p &#x0003c;</italic> 0.01), but had no effect on the mRNA expression level of COX-2 (<xref rid="vetsci-11-00607-f003" ref-type="fig">Figure 3</xref>B,C) in uninfected BMECs. Together, these data demonstrate that MEL dampened the elevated production of COX-2 induced by <italic toggle="yes">K. pneumoniae</italic> in BMECs.</p></sec><sec id="sec3dot4-vetsci-11-00607"><title>3.4. Inflammatory Gene Expression</title><p>The effects of MEL on the pro-inflammatory gene&#x02019;s expression were detected. After <italic toggle="yes">K. pneumoniae</italic> infection, the mRNA expression levels of IL-1&#x003b2;, IL-6, IL-8, and TNF-&#x003b1; were significantly increased (<italic toggle="yes">p</italic> &#x0003c; 0.01) compared with the control group (<xref rid="vetsci-11-00607-f004" ref-type="fig">Figure 4</xref>A&#x02013;D). MEL (0.5 and 5 &#x003bc;M) inhibited the elevation expression of IL-1&#x003b2; and IL-6 (<italic toggle="yes">p</italic> &#x0003c; 0.05 or <italic toggle="yes">p</italic> &#x0003c; 0.01) induced by <italic toggle="yes">K. pneumoniae</italic> compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> alone. In the same context, only 5 &#x003bc;M of MEL significantly inhibited the elevation expression of TNF-&#x003b1; (<italic toggle="yes">p</italic> &#x0003c; 0.05). However, MEL significantly increased the mRNA expression levels of IL-8 compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> alone. These data suggest that the anti-inflammatory effects of MEL on mastitis caused by <italic toggle="yes">K. pneumoniae</italic> is related to inhibition of the production of IL-1&#x003b2;, IL-6, and TNF-&#x003b1; in BMECs.</p></sec><sec id="sec3dot5-vetsci-11-00607"><title>3.5. NF-&#x003ba;B Signaling Pathway Activation</title><p>Considering the important role of NF-&#x003ba;B in the inflammatory process, the present study further investigated the effect of MEL on the NF-&#x003ba;B signaling pathway. The activation of the NF-&#x003ba;B signaling pathway was determined by Western blot and immunofluorescence analysis. As illustrated in <xref rid="vetsci-11-00607-f005" ref-type="fig">Figure 5</xref>A&#x02013;C, the phosphorylation levels of p65 and I&#x003ba;B&#x003b1; proteins were significantly increased in <italic toggle="yes">K. pneumoniae</italic>-infected cells compared with the control group (<italic toggle="yes">p</italic> &#x0003c; 0.01). MEL treatment was able to significantly reduce the phosphorylation levels of p65 (<italic toggle="yes">p</italic> &#x0003c; 0.05 or <italic toggle="yes">p</italic> &#x0003c; 0.01) compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> only. In the same context, 5 &#x003bc;M of MEL treatment inhibited the increased phosphorylation of I&#x003ba;B&#x003b1; proteins induced by <italic toggle="yes">K. pneumoniae</italic> (<italic toggle="yes">p</italic> &#x0003c; 0.01). The results of immunofluorescence also showed that <italic toggle="yes">K. pneumoniae</italic> was able to induce the nuclear accumulation of the p65 protein. Compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> alone, the nuclear accumulation of the p65 protein induced by <italic toggle="yes">K. pneumoniae</italic> infection was reduced in the presence of MEL (<xref rid="vetsci-11-00607-f006" ref-type="fig">Figure 6</xref>). These results indicate that MEL could inhibit the activation of the NF-&#x003ba;B signaling pathway.</p></sec><sec id="sec3dot6-vetsci-11-00607"><title>3.6. Intracellular ROS and MDA Content</title><p>The oxidative milieu of cells was investigated by measuring ROS and MDA. The changes in ROS and MDA in the cells are shown in <xref rid="vetsci-11-00607-f007" ref-type="fig">Figure 7</xref>A&#x02013;C. <italic toggle="yes">K. pneumoniae</italic> infection significantly increases the levels of ROS and MDA (<italic toggle="yes">p</italic> &#x0003c; 0.01) compared with the control group. MEL was able to significantly reduce the increased levels of ROS and MDA induced by <italic toggle="yes">K. pneumoniae</italic> (<italic toggle="yes">p</italic> &#x0003c; 0.01).</p></sec><sec id="sec3dot7-vetsci-11-00607"><title>3.7. T-AOC and Activities of SOD and CAT</title><p>The T-AOC, SOD, and CAT were determined to investigate the effects of MEL on the antioxidant capacity of BMECs. The results showed that <italic toggle="yes">K. pneumoniae</italic> reduced cellular SOD, CAT activity, and T-AOC levels (<italic toggle="yes">p</italic> &#x0003c; 0.01) compared with the control group (<xref rid="vetsci-11-00607-f008" ref-type="fig">Figure 8</xref>A&#x02013;C). MEL was able to elevate the activation of SOD and CAT (<italic toggle="yes">p</italic> &#x0003c; 0.01), and 5 &#x003bc;M of MEL improved the level of T-AOC (<italic toggle="yes">p</italic> &#x0003c; 0.05) compared with the <italic toggle="yes">K. pneumoniae</italic> group. These data prove that MEL can improve the antioxidant capacity and thus reduce the oxidative stress state in <italic toggle="yes">K. pneumoniae</italic>-infected cells.</p></sec><sec id="sec3dot8-vetsci-11-00607"><title>3.8. Nrf2 Signaling Pathway Activation</title><p>Nrf2 is best known for its role in activating the antioxidant response and protecting cells from damage caused by ROS and electrophiles. Thus, the role of the Nrf2 signaling pathway on the antioxidant protective effect of MEL was explored in the <italic toggle="yes">K. pneumoniae</italic>-infected cells. The expression changes in key proteins in the Nrf2 signaling pathway are shown in <xref rid="vetsci-11-00607-f009" ref-type="fig">Figure 9</xref>A&#x02013;F. Keap1 is a key negative regulator protein of Nrf2, and the protein expression levels of Keap1 and Nrf2 were significantly reduced after <italic toggle="yes">K. pneumoniae</italic> infection (<italic toggle="yes">p</italic> &#x0003c; 0.05 or <italic toggle="yes">p</italic> &#x0003c; 0.01) compared with the control group. Consistently, the Nrf2 nuclear accumulation was increased in the infected cells. However, the antioxidant proteins (HO-1 and NQO1) regulated by the Nrf2 signaling pathway were significantly reduced in the infected cells (<italic toggle="yes">p</italic> &#x0003c; 0.05) compared with the control group, which indicates that <italic toggle="yes">K. pneumoniae</italic> induced the activation of the Nrf2 signaling pathway but may inhibit the regulatory role of Nrf2. MEL increased the Nrf2 nuclear accumulation and the protein expression levels of Nrf2, Keap1, HO-1, and NQO1 (<italic toggle="yes">p</italic> &#x0003c; 0.05 or <italic toggle="yes">p</italic> &#x0003c; 0.01) compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> only. Collectively, these results suggest that MEL can activate the Nrf2 signaling pathway and promote the expression of downstream antioxidant proteins.</p></sec></sec><sec sec-type="discussion" id="sec4-vetsci-11-00607"><title>4. Discussion</title><p>Bovine mastitis is recognized worldwide as a disease that poses a great threat to dairy farming, as it leads to huge economic losses and animal welfare issues. <italic toggle="yes">K. pneumoniae</italic> is receiving more attention in herds. This pathogen tends to cause more severe mammary lesions and milk loss than <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> [<xref rid="B3-vetsci-11-00607" ref-type="bibr">3</xref>]. MEL has been approved for supportive therapy for mastitis, in combination with antibiotics, to relieve pain and inflammation. However, its specific effects on BMECs in response to specific pathogens are unknown. A previous study found that MEL at a concentration of 1.5 mg/mL (4268.64 &#x003bc;M) can inhibit the immune response of BMECs in response to LPS and LTA (from <italic toggle="yes">E. coli</italic> and <italic toggle="yes">Staphylococcus aureus</italic>) by preventing increased mRNA expression, such as TNF-&#x003b1;, IL-8, and serum amyloid A [<xref rid="B29-vetsci-11-00607" ref-type="bibr">29</xref>]. However, the concentration of MEL (4268.64 &#x003bc;M) used in the previous study far exceeded the maximum plasma concentration (4.78 &#x003bc;M) in dairy cows that received the recommended therapeutic dose (0.5 mg/kg body weight). Therefore, plasma maintenance concentrations of MEL (0.5 and 5 &#x003bc;M) were selected to clarify its effects on the inflammatory response and oxidative stress in BMECs infected with <italic toggle="yes">K. pneumoniae</italic>. This study demonstrated that MEL at plasma maintenance concentrations exerted no influence on the viability of uninfected BMECs and had also no impact on bacterial load in BMECs. At these concentrations, MEL can inhibit the inflammatory response and increase the antioxidant capacity of BMECs in response to <italic toggle="yes">K. pneumoniae</italic> infection.</p><p>BMECs play a key role in mammary glands against bacterial infection. Cultured BMECs are commonly used to mirror the pathogenicity of different pathogens [<xref rid="B30-vetsci-11-00607" ref-type="bibr">30</xref>,<xref rid="B31-vetsci-11-00607" ref-type="bibr">31</xref>,<xref rid="B32-vetsci-11-00607" ref-type="bibr">32</xref>]. After pathogen infection, BMECs can produce enzymes, cytokines, and chemokines, which are involved in the inflammatory response. COX-2 is an inducible enzyme that contributes to inflammation by catalyzing the production of prostaglandins [<xref rid="B33-vetsci-11-00607" ref-type="bibr">33</xref>]. A high expression of COX-2 has been found in LPS-stimulated BMECs [<xref rid="B34-vetsci-11-00607" ref-type="bibr">34</xref>]. The expression of COX-2 is primarily regulated at the transcriptional level by various transcription factors, including NF-&#x003ba;B, AP-1, and STAT-3 [<xref rid="B35-vetsci-11-00607" ref-type="bibr">35</xref>,<xref rid="B36-vetsci-11-00607" ref-type="bibr">36</xref>]. In the present study, MEL inhibited the protein level of COX-2 in infected and uninfected cells. Moreover, MEL inhibited the elevated mRNA expression of COX-2 induced by <italic toggle="yes">K. pneumoniae</italic> but had no effect on uninfected cells. These data demonstrate that MEL can inhibit the production of COX-2 at the transcriptional level during inflammation in addition to inhibiting COX-2 activity. IL-1&#x003b2;, TNF-&#x003b1;, and IL-6 are important cytokines that are involved in the mammary immune response. The increased mRNA expression levels of IL-1&#x003b2;, TNF-&#x003b1;, and IL-6 were found in <italic toggle="yes">K. pneumoniae</italic>-infected BMECs [<xref rid="B8-vetsci-11-00607" ref-type="bibr">8</xref>]. In the present study, MEL inhibited the increased mRNA expression of IL-1&#x003b2;, TNF-&#x003b1;, and IL-6 induced by <italic toggle="yes">K. pneumoniae</italic>. IL-8, as a chemokine, is produced by various types of cells including macrophages, epithelial cells, and fibroblasts. Under inflammation conditions, IL-8 is released and able to recruit and activate neutrophils to the sites of inflammation [<xref rid="B37-vetsci-11-00607" ref-type="bibr">37</xref>]. It was found that dairy cows with higher levels of IL-8 in whey were more capable of limiting <italic toggle="yes">E. coli</italic> growth in the mammary glands [<xref rid="B38-vetsci-11-00607" ref-type="bibr">38</xref>]. In the current study, the mRNA abundance of IL-8 was upregulated in BMECs after <italic toggle="yes">K. pneumoniae</italic> infection. Interestingly, the addition of MEL further increased the mRNA abundance of IL-8. This result may partly explain why MEL treatment improves the bacteriological cure in mastitis [<xref rid="B23-vetsci-11-00607" ref-type="bibr">23</xref>], which may be related to its enhancement of the production of IL-8 and recruitment of more neutrophils to the infected mammary gland. However, the underlying molecular mechanisms by which MEL promotes the mRNA expression of IL-8 require further study.</p><p>NF-&#x003ba;B is a typical signaling pathway that regulates the pro-inflammatory response to infection [<xref rid="B39-vetsci-11-00607" ref-type="bibr">39</xref>]. The genes&#x02019; expression of cytokines, chemokines, and enzymes that produce inflammatory mediators are largely based on the activation of canonical NF-&#x003ba;B in infected BMECs [<xref rid="B40-vetsci-11-00607" ref-type="bibr">40</xref>,<xref rid="B41-vetsci-11-00607" ref-type="bibr">41</xref>,<xref rid="B42-vetsci-11-00607" ref-type="bibr">42</xref>]. The activation of the canonical NF-&#x003ba;B pathway requires I&#x003ba;B kinase (IKK) subunits and the nuclear translocation of NF-&#x003ba;B p65 [<xref rid="B43-vetsci-11-00607" ref-type="bibr">43</xref>]. In normal cells, the p65 is maintained in the cytoplasm due to binding the inhibitory protein I&#x003ba;B&#x003b1;. IKK&#x003b2; regulates the activation of the NF-&#x003ba;B pathway by phosphorylating I&#x003ba;B&#x003b1;. Phosphorylated I&#x003ba;B&#x003b1; is subsequently ubiquitinated and degraded, resulting in the translocation of p65 from the cytoplasm to the nucleus. The p65 enters the nucleus to promote the transcription of genes encoding cytokines, chemokines, and enzymes [<xref rid="B44-vetsci-11-00607" ref-type="bibr">44</xref>]. Our previous study showed that <italic toggle="yes">K. pneumoniae</italic> was able to activate the NF-&#x003ba;B signaling pathway in BMECs by phosphorylating the I&#x003ba;B&#x003b1; and p65 [<xref rid="B25-vetsci-11-00607" ref-type="bibr">25</xref>], which was again demonstrated in this study. The activation of the NF-&#x003ba;B signaling pathway induced by <italic toggle="yes">K. pneumoniae</italic> can be inhibited by MEL. Collectively, these results indicate that NF-&#x003ba;B inhibition is one of the protective mechanisms through which MEL protects cells from inflammatory damage.</p><p>Oxidative stress and inflammation have an interdependent relationship and are simultaneously present in infection conditions [<xref rid="B45-vetsci-11-00607" ref-type="bibr">45</xref>,<xref rid="B46-vetsci-11-00607" ref-type="bibr">46</xref>]. Since MEL can inhibit the inflammatory response, it may also affect oxidative stress in <italic toggle="yes">K. pneumoniae</italic>-infected cells. The extent of oxidative stress depends on the balance between ROS production and antioxidant defenses. A deficiency in antioxidants or an excessive production of ROS can lead to oxidative stress and cell injury. ROS are an important cause of oxidative stress. They attack various biomolecules, including proteins, DNA, and lipids. Among them, lipids are the most vulnerable to ROS, which is known as lipid peroxidation [<xref rid="B47-vetsci-11-00607" ref-type="bibr">47</xref>]. MDA is the product of lipid peroxidation [<xref rid="B48-vetsci-11-00607" ref-type="bibr">48</xref>]. SOD and the catalase CAT are important enzymatic antioxidants that reduce oxidative damage [<xref rid="B49-vetsci-11-00607" ref-type="bibr">49</xref>]. In this study, <italic toggle="yes">K. pneumoniae</italic> infection induced oxidative stress, manifested as increased ROS and MDA levels, and reduced the activity of SOD and CAT and the level of T-AOC. As expected, oxidative stress that occurred in <italic toggle="yes">K. pneumoniae</italic>-infected cells can be alleviated in the presence of MEL.</p><p>The Nrf2 signaling pathway is a complex network that orchestrates cellular responses to oxidative stress. Nrf2 activity is primary regulated by redox-sensitive cysteine residues within the Keap1 protein. Excessive ROS react with these cysteines, leading to the deactivation of Keap1. Once Keap1 is deactivated, Nrf2 is released from its interaction with Keap1 and can translocate to the nucleus. Then, Nrf2 binds to antioxidant response elements (AREs) that are present in genes encoding antioxidant enzymes like NQO-1, HO-1, SOD, and CAT, which leading to their transcription [<xref rid="B50-vetsci-11-00607" ref-type="bibr">50</xref>]. Disruption of redox signaling contributes to imbalances between oxidants and antioxidants [<xref rid="B51-vetsci-11-00607" ref-type="bibr">51</xref>]. In this study, <italic toggle="yes">K. pneumoniae</italic> infection induced the Nrf2 nuclear accumulation; however, it subsequently inhibited the expression of Nrf2 downstream proteins. We hypothesized that Nrf2 can translocate to the nucleus, but the function of regulating the transcription of downstream genes is inhibited in <italic toggle="yes">K. pneumoniae</italic>-infected cells. Our results showed that MEL could improve the antioxidant capacity by promoting Nrf2 translocation into the nucleus, elevating the expression of HO-1, NQO1, and other antioxidant enzymes.</p></sec><sec sec-type="conclusions" id="sec5-vetsci-11-00607"><title>5. Conclusions</title><p>Plasma maintenance concentrations of MEL (0.5 and 5 &#x003bc;M) were able to reduce the inflammatory responses and oxidative stress in <italic toggle="yes">K. pneumoniae</italic>-infected BMECs. The mechanisms by which MEL attenuates inflammatory responses and oxidative stress is at least partially related to its inhibition of the NF-&#x003ba;B signaling pathway and activation of the Nrf2 signaling pathway. However, the mechanism by which MEL promotes the mRNA expression of IL-8 requires further study. Furthermore, the function of Nrf2 regulating the downstream genes transcription was disturbed in <italic toggle="yes">K. pneumoniae</italic>-infected cells, which should gain more attention.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vetsci-11-00607"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/vetsci11120607/s1">https://www.mdpi.com/article/10.3390/vetsci11120607/s1</uri>, The Western Blot figures.</p><supplementary-material id="vetsci-11-00607-s001" position="float" content-type="local-data"><media xlink:href="vetsci-11-00607-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, K.L., S.Q. and H.W.; methodology, K.L., S.Q. and L.F.; software, S.Q., L.F. and L.G.; validation, K.L. and S.Q.; formal analysis, L.C. and J.D.; data curation, K.L. and S.Q.; writing&#x02014;original draft preparation, K.L. and S.Q.; writing&#x02014;review and editing, X.M. and L.C.; supervision, J.L. and H.W.; project administration, K.L. and H.W.; funding acquisition, K.L. and H.W. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The study protocol was approved by the Animal Care and Ethics Committee of Yangzhou University (approval ID: 202205130).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are available in the article.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></notes><ref-list><title>References</title><ref id="B1-vetsci-11-00607"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aghamohammadi</surname><given-names>M.</given-names></name>
<name><surname>Haine</surname><given-names>D.</given-names></name>
<name><surname>Kelton</surname><given-names>D.F.</given-names></name>
<name><surname>Barkema</surname><given-names>H.W.</given-names></name>
<name><surname>Hogeveen</surname><given-names>H.</given-names></name>
<name><surname>Keefe</surname><given-names>G.P.</given-names></name>
<name><surname>Dufour</surname><given-names>S.</given-names></name>
</person-group><article-title>Herd-Level Mastitis-Associated Costs on Canadian Dairy Farms</article-title><source>Front. Vet. Sci.</source><year>2018</year><volume>5</volume><fpage>100</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.3389/fvets.2018.00100</pub-id><pub-id pub-id-type="pmid">29868620</pub-id>
</element-citation></ref><ref id="B2-vetsci-11-00607"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oliveira</surname><given-names>L.</given-names></name>
<name><surname>Hulland</surname><given-names>C.</given-names></name>
<name><surname>Ruegg</surname><given-names>P.L.</given-names></name>
</person-group><article-title>Characterization of clinical mastitis occurring in cows on 50 large dairy herds in Wisconsin</article-title><source>J. Dairy Sci.</source><year>2013</year><volume>96</volume><fpage>7538</fpage><lpage>7549</lpage><pub-id pub-id-type="doi">10.3168/jds.2012-6078</pub-id><pub-id pub-id-type="pmid">24119795</pub-id>
</element-citation></ref><ref id="B3-vetsci-11-00607"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schukken</surname><given-names>Y.</given-names></name>
<name><surname>Chuff</surname><given-names>M.</given-names></name>
<name><surname>Moroni</surname><given-names>P.</given-names></name>
<name><surname>Gurjar</surname><given-names>A.</given-names></name>
<name><surname>Santisteban</surname><given-names>C.</given-names></name>
<name><surname>Welcome</surname><given-names>F.</given-names></name>
<name><surname>Zadoks</surname><given-names>R.</given-names></name>
</person-group><article-title>The &#x0201c;other&#x0201d; gram-negative bacteria in mastitis: Klebsiella, serratia, and more</article-title><source>Vet. Clin. N. Am. Food Anim. Pract.</source><year>2012</year><volume>28</volume><fpage>239</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.cvfa.2012.04.001</pub-id><pub-id pub-id-type="pmid">22664206</pub-id>
</element-citation></ref><ref id="B4-vetsci-11-00607"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>J.</given-names></name>
<name><surname>Barkema</surname><given-names>H.W.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>G.</given-names></name>
<name><surname>Deng</surname><given-names>Z.</given-names></name>
<name><surname>Cai</surname><given-names>L.</given-names></name>
<name><surname>Shan</surname><given-names>R.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Zou</surname><given-names>J.</given-names></name>
<name><surname>Kastelic</surname><given-names>J.P.</given-names></name>
<etal/>
</person-group><article-title>Incidence of clinical mastitis and distribution of pathogens on large Chinese dairy farms</article-title><source>J. Dairy Sci.</source><year>2017</year><volume>100</volume><fpage>4797</fpage><lpage>4806</lpage><pub-id pub-id-type="doi">10.3168/jds.2016-12334</pub-id><pub-id pub-id-type="pmid">28434736</pub-id>
</element-citation></ref><ref id="B5-vetsci-11-00607"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fuenzalida</surname><given-names>M.J.</given-names></name>
<name><surname>Ruegg</surname><given-names>P.L.</given-names></name>
</person-group><article-title>Negatively controlled, randomized clinical trial to evaluate intramammary treatment of nonsevere, gram-negative clinical mastitis</article-title><source>J. Dairy Sci.</source><year>2019</year><volume>102</volume><fpage>5438</fpage><lpage>5457</lpage><pub-id pub-id-type="doi">10.3168/jds.2018-16156</pub-id><pub-id pub-id-type="pmid">30981475</pub-id>
</element-citation></ref><ref id="B6-vetsci-11-00607"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sampimon</surname><given-names>O.C.</given-names></name>
<name><surname>Sol</surname><given-names>J.</given-names></name>
<name><surname>Kock</surname><given-names>P.A.</given-names></name>
</person-group><article-title>An outbreak of <italic toggle="yes">Klebsiella pneumoniae</italic> mastitis</article-title><source>Tijdschr. Diergeneeskd.</source><year>2006</year><volume>131</volume><fpage>2</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">16430158</pub-id>
</element-citation></ref><ref id="B7-vetsci-11-00607"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zheng</surname><given-names>Z.</given-names></name>
<name><surname>Gorden</surname><given-names>P.J.</given-names></name>
<name><surname>Xia</surname><given-names>X.</given-names></name>
<name><surname>Zheng</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>G.</given-names></name>
</person-group><article-title>Whole-genome analysis <italic toggle="yes">of Klebsiella pneumoniae</italic> from bovine mastitis milk in the U.S</article-title><source>Environ. Microbiol.</source><year>2022</year><volume>24</volume><fpage>1183</fpage><lpage>1199</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.15721</pub-id><pub-id pub-id-type="pmid">34398526</pub-id>
</element-citation></ref><ref id="B8-vetsci-11-00607"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Han</surname><given-names>B.</given-names></name>
<name><surname>Barkema</surname><given-names>H.W.</given-names></name>
<name><surname>Cobo</surname><given-names>E.R.</given-names></name>
<name><surname>Kastelic</surname><given-names>J.P.</given-names></name>
<name><surname>Zhou</surname><given-names>M.</given-names></name>
<name><surname>Shi</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Klebsiella pneumoniae isolated from bovine mastitis is cytopathogenic for bovine mammary epithelial cells</article-title><source>J. Dairy Sci.</source><year>2020</year><volume>103</volume><fpage>3493</fpage><lpage>3504</lpage><pub-id pub-id-type="doi">10.3168/jds.2019-17458</pub-id><pub-id pub-id-type="pmid">32037181</pub-id>
</element-citation></ref><ref id="B9-vetsci-11-00607"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fitzpatrick</surname><given-names>C.E.</given-names></name>
<name><surname>Chapinal</surname><given-names>N.</given-names></name>
<name><surname>Petersson-Wolfe</surname><given-names>C.S.</given-names></name>
<name><surname>DeVries</surname><given-names>T.J.</given-names></name>
<name><surname>Kelton</surname><given-names>D.F.</given-names></name>
<name><surname>Duffield</surname><given-names>T.F.</given-names></name>
<name><surname>Leslie</surname><given-names>K.E.</given-names></name>
</person-group><article-title>The effect of meloxicam on pain sensitivity, rumination time, and clinical signs in dairy cows with endotoxin-induced clinical mastitis</article-title><source>J. Dairy Sci.</source><year>2013</year><volume>96</volume><fpage>2847</fpage><lpage>2856</lpage><pub-id pub-id-type="doi">10.3168/jds.2012-5855</pub-id><pub-id pub-id-type="pmid">23522672</pub-id>
</element-citation></ref><ref id="B10-vetsci-11-00607"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Noble</surname><given-names>S.</given-names></name>
<name><surname>Balfour</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Meloxicam</article-title><source>Drugs</source><year>1996</year><volume>51</volume><fpage>424</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.2165/00003495-199651030-00007</pub-id><pub-id pub-id-type="pmid">8882380</pub-id>
</element-citation></ref><ref id="B11-vetsci-11-00607"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ricciotti</surname><given-names>E.</given-names></name>
<name><surname>FitzGerald</surname><given-names>G.A.</given-names></name>
</person-group><article-title>Prostaglandins and inflammation</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2011</year><volume>31</volume><fpage>986</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.110.207449</pub-id><pub-id pub-id-type="pmid">21508345</pub-id>
</element-citation></ref><ref id="B12-vetsci-11-00607"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gilroy</surname><given-names>D.W.</given-names></name>
<name><surname>Colville-Nash</surname><given-names>P.R.</given-names></name>
<name><surname>Willis</surname><given-names>D.</given-names></name>
<name><surname>Chivers</surname><given-names>J.</given-names></name>
<name><surname>Paul-Clark</surname><given-names>M.J.</given-names></name>
<name><surname>Willoughby</surname><given-names>D.A.</given-names></name>
</person-group><article-title>Inducible cyclooxygenase may have anti-inflammatory properties</article-title><source>Nat. Med.</source><year>1999</year><volume>5</volume><fpage>698</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1038/9550</pub-id><pub-id pub-id-type="pmid">10371510</pub-id>
</element-citation></ref><ref id="B13-vetsci-11-00607"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gilbert</surname><given-names>F.B.</given-names></name>
<name><surname>Cunha</surname><given-names>P.</given-names></name>
<name><surname>Jensen</surname><given-names>K.</given-names></name>
<name><surname>Glass</surname><given-names>E.J.</given-names></name>
<name><surname>Foucras</surname><given-names>G.</given-names></name>
<name><surname>Robert-Grani&#x000e9;</surname><given-names>C.</given-names></name>
<name><surname>Rupp</surname><given-names>R.</given-names></name>
<name><surname>Rainard</surname><given-names>P.</given-names></name>
</person-group><article-title>Differential response of bovine mammary epithelial cells to <italic toggle="yes">Staphylococcus aureus</italic> or <italic toggle="yes">Escherichia coli</italic> agonists of the innate immune system</article-title><source>Vet. Res.</source><year>2013</year><volume>44</volume><fpage>40</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1186/1297-9716-44-40</pub-id><pub-id pub-id-type="pmid">23758654</pub-id>
</element-citation></ref><ref id="B14-vetsci-11-00607"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Akira</surname><given-names>S.</given-names></name>
<name><surname>Takeda</surname><given-names>K.</given-names></name>
<name><surname>Kaisho</surname><given-names>T.</given-names></name>
</person-group><article-title>Toll-like receptors: Critical proteins linking innate and acquired immunity</article-title><source>Nat. Immunol.</source><year>2001</year><volume>2</volume><fpage>675</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1038/90609</pub-id><pub-id pub-id-type="pmid">11477402</pub-id>
</element-citation></ref><ref id="B15-vetsci-11-00607"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harada</surname><given-names>A.</given-names></name>
<name><surname>Sekido</surname><given-names>N.</given-names></name>
<name><surname>Akahoshi</surname><given-names>T.</given-names></name>
<name><surname>Wada</surname><given-names>T.</given-names></name>
<name><surname>Mukaida</surname><given-names>N.</given-names></name>
<name><surname>Matsushima</surname><given-names>K.</given-names></name>
</person-group><article-title>Essential involvement of interleukin-8 (IL-8) in acute inflammation</article-title><source>J. Leukoc. Biol.</source><year>1994</year><volume>56</volume><fpage>559</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1002/jlb.56.5.559</pub-id><pub-id pub-id-type="pmid">7964163</pub-id>
</element-citation></ref><ref id="B16-vetsci-11-00607"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dinarello</surname><given-names>C.A.</given-names></name>
</person-group><article-title>Cytokines as mediators in the pathogenesis of septic shock</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>1996</year><volume>216</volume><fpage>133</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">8791739</pub-id>
</element-citation></ref><ref id="B17-vetsci-11-00607"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bannerman</surname><given-names>D.D.</given-names></name>
<name><surname>Paape</surname><given-names>M.J.</given-names></name>
<name><surname>Hare</surname><given-names>W.R.</given-names></name>
<name><surname>Hope</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Characterization of the bovine innate immune response to intramammary infection with Klebsiella pneumoniae</article-title><source>J. Dairy Sci.</source><year>2004</year><volume>87</volume><fpage>2420</fpage><lpage>2432</lpage><pub-id pub-id-type="doi">10.3168/jds.S0022-0302(04)73365-2</pub-id><pub-id pub-id-type="pmid">15328264</pub-id>
</element-citation></ref><ref id="B18-vetsci-11-00607"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>S.</given-names></name>
<name><surname>Miao</surname><given-names>Y.</given-names></name>
<name><surname>Dong</surname><given-names>J.</given-names></name>
<name><surname>Cui</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>K.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Meng</surname><given-names>X.</given-names></name>
<name><surname>Zhu</surname><given-names>G.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
</person-group><article-title>Selenomethionine Inhibits NF-&#x003ba;B-mediated Inflammatory Responses of Bovine Mammary Epithelial Cells Caused by <italic toggle="yes">Klebsiella pneumoniae</italic> by Increasing Autophagic Flux</article-title><source>Biol. Trace Elem. Res.</source><year>2024</year><volume>202</volume><fpage>1568</fpage><lpage>1581</lpage><pub-id pub-id-type="doi">10.1007/s12011-023-03757-2</pub-id><pub-id pub-id-type="pmid">37407885</pub-id>
</element-citation></ref><ref id="B19-vetsci-11-00607"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rongvaux</surname><given-names>A.</given-names></name>
</person-group><article-title>Innate immunity and tolerance toward mitochondria</article-title><source>Mitochondrion</source><year>2018</year><volume>41</volume><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.mito.2017.10.007</pub-id><pub-id pub-id-type="pmid">29054471</pub-id>
</element-citation></ref><ref id="B20-vetsci-11-00607"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Yi</surname><given-names>B.</given-names></name>
<name><surname>Liu</surname><given-names>G.</given-names></name>
<name><surname>Zhou</surname><given-names>M.</given-names></name>
<name><surname>Kastelic</surname><given-names>J.P.</given-names></name>
<name><surname>Han</surname><given-names>B.</given-names></name>
<name><surname>Gao</surname><given-names>J.</given-names></name>
</person-group><article-title>Klebsiella pneumoniae infection causes mitochondrial damage and dysfunction in bovine mammary epithelial cells</article-title><source>Vet. Res.</source><year>2021</year><volume>52</volume><fpage>17</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1186/s13567-021-00898-x</pub-id><pub-id pub-id-type="pmid">33568211</pub-id>
</element-citation></ref><ref id="B21-vetsci-11-00607"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Tan</surname><given-names>J.</given-names></name>
<name><surname>Miao</surname><given-names>Y.</given-names></name>
<name><surname>Lei</surname><given-names>P.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
</person-group><article-title>ROS and Autophagy: Interactions and Molecular Regulatory Mechanisms</article-title><source>Cell Mol. Neurobiol.</source><year>2015</year><volume>35</volume><fpage>615</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1007/s10571-015-0166-x</pub-id><pub-id pub-id-type="pmid">25722131</pub-id>
</element-citation></ref><ref id="B22-vetsci-11-00607"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McDougall</surname><given-names>S.</given-names></name>
<name><surname>Bryan</surname><given-names>M.A.</given-names></name>
<name><surname>Tiddy</surname><given-names>R.M.</given-names></name>
</person-group><article-title>Effect of treatment with the nonsteroidal antiinflammatory meloxicam on milk production, somatic cell count, probability of re-treatment, and culling of dairy cows with mild clinical mastitis</article-title><source>J. Dairy Sci.</source><year>2009</year><volume>92</volume><fpage>4421</fpage><lpage>4431</lpage><pub-id pub-id-type="doi">10.3168/jds.2009-2284</pub-id><pub-id pub-id-type="pmid">19700702</pub-id>
</element-citation></ref><ref id="B23-vetsci-11-00607"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McDougall</surname><given-names>S.</given-names></name>
<name><surname>Abbeloos</surname><given-names>E.</given-names></name>
<name><surname>Piepers</surname><given-names>S.</given-names></name>
<name><surname>Rao</surname><given-names>A.S.</given-names></name>
<name><surname>Astiz</surname><given-names>S.</given-names></name>
<name><surname>van Werven</surname><given-names>T.</given-names></name>
<name><surname>Statham</surname><given-names>J.</given-names></name>
<name><surname>P&#x000e9;rez-Villalobos</surname><given-names>N.</given-names></name>
</person-group><article-title>Addition of meloxicam to the treatment of clinical mastitis improves subsequent reproductive performance</article-title><source>J. Dairy Sci.</source><year>2016</year><volume>99</volume><fpage>2026</fpage><lpage>2042</lpage><pub-id pub-id-type="doi">10.3168/jds.2015-9615</pub-id><pub-id pub-id-type="pmid">26778316</pub-id>
</element-citation></ref><ref id="B24-vetsci-11-00607"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Zhou</surname><given-names>Y.</given-names></name>
<name><surname>Zhu</surname><given-names>Q.</given-names></name>
<name><surname>Zang</surname><given-names>H.</given-names></name>
<name><surname>Cai</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Cui</surname><given-names>L.</given-names></name>
<name><surname>Meng</surname><given-names>X.</given-names></name>
<name><surname>Zhu</surname><given-names>G.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> induces autophagy in bovine mammary epithelial cells and the formation of autophagosomes facilitates intracellular replication of <italic toggle="yes">Staph. aureus</italic></article-title><source>J. Dairy Sci.</source><year>2019</year><volume>102</volume><fpage>8264</fpage><lpage>8272</lpage><pub-id pub-id-type="doi">10.3168/jds.2019-16414</pub-id><pub-id pub-id-type="pmid">31255277</pub-id>
</element-citation></ref><ref id="B25-vetsci-11-00607"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>X.</given-names></name>
<name><surname>Xu</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Cui</surname><given-names>L.</given-names></name>
<name><surname>Dong</surname><given-names>J.</given-names></name>
<name><surname>Meng</surname><given-names>X.</given-names></name>
<name><surname>Zhu</surname><given-names>G.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
</person-group><article-title>Selenomethionine protected BMECs from inflammatory injury and oxidative damage induced <italic toggle="yes">by Klebsiella pneumoniae</italic> by inhibiting the NF-&#x003ba;B and activating the Nrf2 signaling pathway</article-title><source>Int. Immunopharmacol.</source><year>2022</year><volume>110</volume><fpage>109027</fpage><pub-id pub-id-type="doi">10.1016/j.intimp.2022.109027</pub-id><pub-id pub-id-type="pmid">35820365</pub-id>
</element-citation></ref><ref id="B26-vetsci-11-00607"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Z.B.</given-names></name>
<name><surname>Guo</surname><given-names>Y.F.</given-names></name>
<name><surname>Li</surname><given-names>C.Y.</given-names></name>
<name><surname>Qiu</surname><given-names>C.W.</given-names></name>
<name><surname>Guo</surname><given-names>M.Y.</given-names></name>
</person-group><article-title>Selenium influences mmu-miR-155 to inhibit inflammation in <italic toggle="yes">Staphylococcus aureus</italic>-induced mastitis in mice</article-title><source>Food Funct.</source><year>2019</year><volume>10</volume><fpage>6543</fpage><lpage>6555</lpage><pub-id pub-id-type="doi">10.1039/C9FO01488H</pub-id><pub-id pub-id-type="pmid">31545328</pub-id>
</element-citation></ref><ref id="B27-vetsci-11-00607"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hisaeda</surname><given-names>K.</given-names></name>
<name><surname>Nohara</surname><given-names>M.</given-names></name>
<name><surname>Ohta</surname><given-names>N.</given-names></name>
<name><surname>Goto</surname><given-names>A.</given-names></name>
<name><surname>Inoue</surname><given-names>Y.</given-names></name>
<name><surname>Hata</surname><given-names>A.</given-names></name>
<name><surname>Shinozuka</surname><given-names>Y.</given-names></name>
</person-group><article-title>Effect of 2% meloxicam injection in Holstein dairy cows on acute clinical mastitis without systemic symptoms</article-title><source>J. Vet. Med. Sci.</source><year>2024</year><volume>86</volume><fpage>374</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1292/jvms.23-0424</pub-id><pub-id pub-id-type="pmid">38325838</pub-id>
</element-citation></ref><ref id="B28-vetsci-11-00607"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shock</surname><given-names>D.</given-names></name>
<name><surname>Roche</surname><given-names>S.</given-names></name>
<name><surname>Olson</surname><given-names>M.</given-names></name>
</person-group><article-title>A Comparative Pharmacokinetic Analysis of Oral and Subcutaneous Meloxicam Administered to Postpartum Dairy Cows</article-title><source>Vet. Sci.</source><year>2019</year><volume>6</volume><elocation-id>73</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci6030073</pub-id><pub-id pub-id-type="pmid">31491858</pub-id>
</element-citation></ref><ref id="B29-vetsci-11-00607"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Caldeira</surname><given-names>M.O.</given-names></name>
<name><surname>Bruckmaier</surname><given-names>R.M.</given-names></name>
<name><surname>Wellnitz</surname><given-names>O.</given-names></name>
</person-group><article-title>Meloxicam affects the inflammatory responses of bovine mammary epithelial cells</article-title><source>J. Dairy Sci.</source><year>2019</year><volume>102</volume><fpage>10277</fpage><lpage>10290</lpage><pub-id pub-id-type="doi">10.3168/jds.2019-16630</pub-id><pub-id pub-id-type="pmid">31447141</pub-id>
</element-citation></ref><ref id="B30-vetsci-11-00607"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Griesbeck-Zilch</surname><given-names>B.</given-names></name>
<name><surname>Meyer</surname><given-names>H.H.</given-names></name>
<name><surname>K&#x000fc;hn</surname><given-names>C.H.</given-names></name>
<name><surname>Schwerin</surname><given-names>M.</given-names></name>
<name><surname>Wellnitz</surname><given-names>O.</given-names></name>
</person-group><article-title>Staphylococcus aureus and <italic toggle="yes">Escherichia coli</italic> cause deviating expression profiles of cytokines and lactoferrin messenger ribonucleic acid in mammary epithelial cells</article-title><source>J. Dairy Sci.</source><year>2008</year><volume>91</volume><fpage>2215</fpage><lpage>2224</lpage><pub-id pub-id-type="doi">10.3168/jds.2007-0752</pub-id><pub-id pub-id-type="pmid">18487644</pub-id>
</element-citation></ref><ref id="B31-vetsci-11-00607"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sintes</surname><given-names>G.F.</given-names></name>
<name><surname>Bruckmaier</surname><given-names>R.M.</given-names></name>
<name><surname>Wellnitz</surname><given-names>O.</given-names></name>
</person-group><article-title>Nonsteroidal anti-inflammatory drugs affect the mammary epithelial barrier during inflammation</article-title><source>J. Dairy Sci.</source><year>2020</year><volume>103</volume><fpage>10742</fpage><lpage>10753</lpage><pub-id pub-id-type="doi">10.3168/jds.2020-18818</pub-id><pub-id pub-id-type="pmid">32896404</pub-id>
</element-citation></ref><ref id="B32-vetsci-11-00607"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>M.</given-names></name>
<name><surname>Song</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Jiang</surname><given-names>X.</given-names></name>
<name><surname>Yin</surname><given-names>P.</given-names></name>
<name><surname>Wan</surname><given-names>C.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>F.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
</person-group><article-title>The protective effect of caffeic acid against inflammation injury of primary bovine mammary epithelial cells induced by lipopolysaccharide</article-title><source>J. Dairy Sci.</source><year>2014</year><volume>97</volume><fpage>2856</fpage><lpage>2865</lpage><pub-id pub-id-type="doi">10.3168/jds.2013-7600</pub-id><pub-id pub-id-type="pmid">24612802</pub-id>
</element-citation></ref><ref id="B33-vetsci-11-00607"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Choi</surname><given-names>S.</given-names></name>
<name><surname>Lim</surname><given-names>J.W.</given-names></name>
<name><surname>Kim</surname><given-names>H.</given-names></name>
</person-group><article-title>Effect of thiol antioxidants on lipopolysaccharide-induced cyclooxygenase-2 expression in pulmonary epithelial cells</article-title><source>J. Physiol. Pharmacol.</source><year>2018</year><volume>69</volume></element-citation></ref><ref id="B34-vetsci-11-00607"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>M.</given-names></name>
<name><surname>Lu</surname><given-names>G.</given-names></name>
<name><surname>Wang</surname><given-names>R.</given-names></name>
<name><surname>Wei</surname><given-names>Y.</given-names></name>
<name><surname>Guo</surname><given-names>Y.</given-names></name>
<name><surname>Yu</surname><given-names>Y.</given-names></name>
<name><surname>Jiang</surname><given-names>C.</given-names></name>
</person-group><article-title>Anti-inflammation of epicatechin mediated by TMEM35A and TMPO in bovine mammary epithelial cell line cells and mouse mammary gland</article-title><source>J. Dairy Sci.</source><year>2021</year><volume>104</volume><fpage>12925</fpage><lpage>12938</lpage><pub-id pub-id-type="doi">10.3168/jds.2021-20571</pub-id><pub-id pub-id-type="pmid">34593235</pub-id>
</element-citation></ref><ref id="B35-vetsci-11-00607"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>G.Y.</given-names></name>
<name><surname>Christman</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases</article-title><source>Am. J. Physiol. Lung Cell Mol. Physiol.</source><year>2006</year><volume>290</volume><fpage>797</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00513.2005</pub-id></element-citation></ref><ref id="B36-vetsci-11-00607"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H.S.</given-names></name>
<name><surname>Ye</surname><given-names>S.K.</given-names></name>
<name><surname>Cho</surname><given-names>I.H.</given-names></name>
<name><surname>Jung</surname><given-names>J.E.</given-names></name>
<name><surname>Kim</surname><given-names>D.H.</given-names></name>
<name><surname>Choi</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>Y.S.</given-names></name>
<name><surname>Park</surname><given-names>C.G.</given-names></name>
<name><surname>Kim</surname><given-names>T.Y.</given-names></name>
<name><surname>Lee</surname><given-names>J.W.</given-names></name>
<etal/>
</person-group><article-title>8-hydroxydeoxyguanosine suppresses NO production and COX-2 activity via Rac1/STATs signaling in LPS-induced brain microglia</article-title><source>Free Radic. Biol. Med.</source><year>2006</year><volume>41</volume><fpage>1392</fpage><lpage>1403</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2006.07.018</pub-id><pub-id pub-id-type="pmid">17023266</pub-id>
</element-citation></ref><ref id="B37-vetsci-11-00607"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matsushima</surname><given-names>K.</given-names></name>
<name><surname>Yang</surname><given-names>D.</given-names></name>
<name><surname>Oppenheim</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Interleukin-8: An evolving chemokine</article-title><source>Cytokine</source><year>2022</year><volume>153</volume><fpage>155828</fpage><lpage>155835</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2022.155828</pub-id><pub-id pub-id-type="pmid">35247648</pub-id>
</element-citation></ref><ref id="B38-vetsci-11-00607"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Korkmaz</surname><given-names>F.T.</given-names></name>
<name><surname>Elsasser</surname><given-names>T.H.</given-names></name>
<name><surname>Kerr</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Variation in fibroblast expression of toll-like receptor 4 and lipopolysaccharide-induced cytokine production between animals predicts control of bacterial growth but not severity of <italic toggle="yes">Escherichia coli mastitis</italic></article-title><source>J. Dairy Sci.</source><year>2018</year><volume>101</volume><fpage>10098</fpage><lpage>10115</lpage><pub-id pub-id-type="doi">10.3168/jds.2017-14372</pub-id><pub-id pub-id-type="pmid">30172411</pub-id>
</element-citation></ref><ref id="B39-vetsci-11-00607"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rahman</surname><given-names>M.M.</given-names></name>
<name><surname>McFadden</surname><given-names>G.</given-names></name>
</person-group><article-title>Modulation of NF-&#x003ba;B signalling by microbial pathogens</article-title><source>Nat. Rev. Microbiol.</source><year>2011</year><volume>9</volume><fpage>291</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2539</pub-id><pub-id pub-id-type="pmid">21383764</pub-id>
</element-citation></ref><ref id="B40-vetsci-11-00607"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>W.</given-names></name>
<name><surname>He</surname><given-names>F.</given-names></name>
<name><surname>Barkema</surname><given-names>H.W.</given-names></name>
<name><surname>Xu</surname><given-names>S.</given-names></name>
<name><surname>Gao</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>G.</given-names></name>
<name><surname>Deng</surname><given-names>Z.</given-names></name>
<name><surname>Shahid</surname><given-names>M.</given-names></name>
<name><surname>Shi</surname><given-names>Y.</given-names></name>
<name><surname>Kastelic</surname><given-names>J.P.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">Prototheca</italic> spp. induce an inflammatory response via mtROS-mediated activation of NF-&#x003ba;B and NLRP3 inflammasome pathways in bovine mammary epithelial cell cultures</article-title><source>Vet. Res.</source><year>2021</year><volume>52</volume><fpage>144</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1186/s13567-021-01014-9</pub-id><pub-id pub-id-type="pmid">34895324</pub-id>
</element-citation></ref><ref id="B41-vetsci-11-00607"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>W.</given-names></name>
<name><surname>Zerbe</surname><given-names>H.</given-names></name>
<name><surname>Petzl</surname><given-names>W.</given-names></name>
<name><surname>Brunner</surname><given-names>R.M.</given-names></name>
<name><surname>G&#x000fc;nther</surname><given-names>J.</given-names></name>
<name><surname>Draing</surname><given-names>C.</given-names></name>
<name><surname>von Aulock</surname><given-names>S.</given-names></name>
<name><surname>Schuberth</surname><given-names>H.J.</given-names></name>
<name><surname>Seyfert</surname><given-names>H.M.</given-names></name>
</person-group><article-title>Bovine TLR2 and TLR4 properly transduce signals from <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">E. coli</italic>, but <italic toggle="yes">S. aureus</italic> fails to both activate NF-kappaB in mammary epithelial cells and to quickly induce TNFalpha and interleukin-8 (CXCL8) expression in the udder</article-title><source>Mol. Immunol.</source><year>2008</year><volume>45</volume><fpage>1385</fpage><lpage>1397</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2007.09.004</pub-id><pub-id pub-id-type="pmid">17936907</pub-id>
</element-citation></ref><ref id="B42-vetsci-11-00607"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fu</surname><given-names>Y.</given-names></name>
<name><surname>Zhou</surname><given-names>E.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>F.</given-names></name>
<name><surname>Liang</surname><given-names>D.</given-names></name>
<name><surname>Liu</surname><given-names>B.</given-names></name>
<name><surname>Song</surname><given-names>X.</given-names></name>
<name><surname>Zhao</surname><given-names>F.</given-names></name>
<name><surname>Fen</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Escherichia coli</italic> elicit different innate immune responses from bovine mammary epithelial cells</article-title><source>Vet. Immunol. Immunopathol.</source><year>2013</year><volume>155</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2013.08.003</pub-id><pub-id pub-id-type="pmid">24018311</pub-id>
</element-citation></ref><ref id="B43-vetsci-11-00607"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lawrence</surname><given-names>T.</given-names></name>
</person-group><article-title>The nuclear factor NF-kappaB pathway in inflammation</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2009</year><volume>1</volume><elocation-id>a001651</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a001651</pub-id><pub-id pub-id-type="pmid">20457564</pub-id>
</element-citation></ref><ref id="B44-vetsci-11-00607"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hayden</surname><given-names>M.S.</given-names></name>
<name><surname>Ghosh</surname><given-names>S.</given-names></name>
</person-group><article-title>NF-&#x003ba;B in immunobiology</article-title><source>Cell Res.</source><year>2011</year><volume>21</volume><fpage>223</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1038/cr.2011.13</pub-id><pub-id pub-id-type="pmid">21243012</pub-id>
</element-citation></ref><ref id="B45-vetsci-11-00607"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mittal</surname><given-names>M.</given-names></name>
<name><surname>Siddiqui</surname><given-names>M.R.</given-names></name>
<name><surname>Tran</surname><given-names>K.</given-names></name>
<name><surname>Reddy</surname><given-names>S.P.</given-names></name>
<name><surname>Malik</surname><given-names>A.B.</given-names></name>
</person-group><article-title>Reactive oxygen species in inflammation and tissue injury</article-title><source>Antioxid. Redox Signal.</source><year>2014</year><volume>20</volume><fpage>1126</fpage><lpage>1167</lpage><pub-id pub-id-type="doi">10.1089/ars.2012.5149</pub-id><pub-id pub-id-type="pmid">23991888</pub-id>
</element-citation></ref><ref id="B46-vetsci-11-00607"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fialkow</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Downey</surname><given-names>G.P.</given-names></name>
</person-group><article-title>Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function</article-title><source>Free Radic. Biol. Med.</source><year>2007</year><volume>42</volume><fpage>153</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2006.09.030</pub-id><pub-id pub-id-type="pmid">17189821</pub-id>
</element-citation></ref><ref id="B47-vetsci-11-00607"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Razavi</surname><given-names>S.M.</given-names></name>
<name><surname>Soltan</surname><given-names>M.S.</given-names></name>
<name><surname>Abbasian</surname><given-names>K.</given-names></name>
<name><surname>Karami</surname><given-names>A.</given-names></name>
<name><surname>Nazifi</surname><given-names>S.</given-names></name>
</person-group><article-title>Host oxidative stress in piroplasmosis: A review in domestic animals</article-title><source>Vet. Parasitol.</source><year>2023</year><volume>322</volume><fpage>110011</fpage><lpage>110017</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2023.110011</pub-id><pub-id pub-id-type="pmid">37643565</pub-id>
</element-citation></ref><ref id="B48-vetsci-11-00607"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsikas</surname><given-names>D.</given-names></name>
</person-group><article-title>Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges</article-title><source>Anal. Biochem.</source><year>2017</year><volume>524</volume><fpage>13</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2016.10.021</pub-id><pub-id pub-id-type="pmid">27789233</pub-id>
</element-citation></ref><ref id="B49-vetsci-11-00607"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scandalios</surname><given-names>J.G.</given-names></name>
</person-group><article-title>Oxidative stress: Molecular perception and transduction of signals triggering antioxidant gene defenses</article-title><source>Braz. J. Med. Biol. Res.</source><year>2005</year><volume>38</volume><fpage>995</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1590/S0100-879X2005000700003</pub-id><pub-id pub-id-type="pmid">16007271</pub-id>
</element-citation></ref><ref id="B50-vetsci-11-00607"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>F.</given-names></name>
<name><surname>Ru</surname><given-names>X.</given-names></name>
<name><surname>Wen</surname><given-names>T.</given-names></name>
</person-group><article-title>NRF2, a Transcription Factor for Stress Response and Beyond</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>4777</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21134777</pub-id><pub-id pub-id-type="pmid">32640524</pub-id>
</element-citation></ref><ref id="B51-vetsci-11-00607"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jones</surname><given-names>D.P.</given-names></name>
</person-group><article-title>Redefining oxidative stress</article-title><source>Antioxid. Redox Signal.</source><year>2006</year><volume>8</volume><fpage>1865</fpage><lpage>1879</lpage><pub-id pub-id-type="doi">10.1089/ars.2006.8.1865</pub-id><pub-id pub-id-type="pmid">16987039</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vetsci-11-00607-f001"><label>Figure 1</label><caption><p>The effects of MEL on cell viability. BMECs were treated with different concentrations (0, 0.5, 5, 10, 20, and 40 &#x003bc;&#x0039c;) of MEL for 12 h. The cell viability was evaluated with the CCK-8 method.</p></caption><graphic xlink:href="vetsci-11-00607-g001" position="float"/></fig><fig position="float" id="vetsci-11-00607-f002"><label>Figure 2</label><caption><p>The effects of MEL on bacterial load. BMECs were infected with <italic toggle="yes">K. pneumoniae</italic> for 3 h in the presence or absence of MEL. Each experiment was repeated 4 times.</p></caption><graphic xlink:href="vetsci-11-00607-g002" position="float"/></fig><fig position="float" id="vetsci-11-00607-f003"><label>Figure 3</label><caption><p>The effects of MEL on the mRNA expression (<bold>A</bold>) and protein levels (<bold>B</bold>,<bold>C</bold>) of COX-2 in BMECs. BMECs were infected with <italic toggle="yes">K. pneumoniae</italic> for 3 h in the presence or absence of MEL. <italic toggle="yes"># p</italic> &#x0003c; 0.05 and ## <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the control group. * <italic toggle="yes">p</italic> &#x0003c; 0.05 and ** <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> alone (see <xref rid="app1-vetsci-11-00607" ref-type="app">Supplementary Materials</xref>).</p></caption><graphic xlink:href="vetsci-11-00607-g003" position="float"/></fig><fig position="float" id="vetsci-11-00607-f004"><label>Figure 4</label><caption><p>The effects of MEL on the mRNA expression of IL-1&#x003b2; (<bold>A</bold>), IL-6 (<bold>B</bold>), IL-8 (<bold>C</bold>), and TNF-&#x003b1; (<bold>D</bold>) in BMECs. BMECs were infected with <italic toggle="yes">K. pneumoniae</italic> for 3 h in the presence or absence of MEL. ## <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the control group. * <italic toggle="yes">p</italic> &#x0003c; 0.05 and ** <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> alone.</p></caption><graphic xlink:href="vetsci-11-00607-g004" position="float"/></fig><fig position="float" id="vetsci-11-00607-f005"><label>Figure 5</label><caption><p>The effects of MEL on the NF-&#x003ba;B signaling pathway. BMECs were infected with <italic toggle="yes">K. pneumoniae</italic> for 1 h in the presence or absence of MEL. (<bold>A</bold>) The protein expression of p-p65, p65, p-I&#x003ba;B&#x003b1;, and I&#x003ba;B&#x003b1; in BMECs (see <xref rid="app1-vetsci-11-00607" ref-type="app">Supplementary Materials</xref>). (<bold>B</bold>) Changes in the phosphorylation level of p65. (<bold>C</bold>) Changes in the phosphorylation level of I&#x003ba;B&#x003b1;. ## <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the control group. * <italic toggle="yes">p</italic> &#x0003c; 0.05 and ** <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> alone.</p></caption><graphic xlink:href="vetsci-11-00607-g005" position="float"/></fig><fig position="float" id="vetsci-11-00607-f006"><label>Figure 6</label><caption><p>The effect of MEL on the nuclear accumulation of the p65 protein in BMECs. BMECs were infected with <italic toggle="yes">K. pneumoniae</italic> for 1 h in the presence or absence of MEL.</p></caption><graphic xlink:href="vetsci-11-00607-g006" position="float"/></fig><fig position="float" id="vetsci-11-00607-f007"><label>Figure 7</label><caption><p>The effects of MEL on the oxidative state of BMECs. (<bold>A</bold>,<bold>B</bold>) Changes in the level of ROS. (<bold>C</bold>) Changes in the level of MDA. BMECs were infected with <italic toggle="yes">K. pneumoniae</italic> for 3 h in the presence or absence of MEL. ## <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the control group. ** <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> alone.</p></caption><graphic xlink:href="vetsci-11-00607-g007" position="float"/></fig><fig position="float" id="vetsci-11-00607-f008"><label>Figure 8</label><caption><p>The effects of MEL on the antioxidant capacity of BMECs. BMECs were infected with <italic toggle="yes">K. pneumoniae</italic> for 3 h in the presence or absence of MEL. The activity of SOD (<bold>A</bold>) and CAT (<bold>B</bold>) and the level of T-AOC (<bold>C</bold>) were detected using commercial kits. ## <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the control group. * <italic toggle="yes">p</italic> &#x0003c; 0.05 and ** <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> alone.</p></caption><graphic xlink:href="vetsci-11-00607-g008" position="float"/></fig><fig position="float" id="vetsci-11-00607-f009"><label>Figure 9</label><caption><p>The effects of MEL on the Nrf2 signaling pathway in BMECs. (<bold>A</bold>) The key proteins expressed in the Nrf2 signaling pathway were detected by Western blot (see <xref rid="app1-vetsci-11-00607" ref-type="app">Supplementary Materials</xref>). (<bold>B</bold>) Changes in Nrf2 nuclear accumulation. Nuclear protein was extracted from cells. The protein expression levels of Nrf2 (<bold>C</bold>), Keap1 (<bold>D</bold>), HO-1 (<bold>E</bold>), and NQO1 (<bold>F</bold>) were detected using total protein. BMECs were infected with <italic toggle="yes">K. pneumoniae</italic> for 3 h in the presence or absence of MEL. <italic toggle="yes"># p</italic> &#x0003c; 0.05 and ## <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the control group. * <italic toggle="yes">p</italic> &#x0003c; 0.05 and ** <italic toggle="yes">p</italic> &#x0003c; 0.01 compared with the group infected with <italic toggle="yes">K. pneumoniae</italic> alone.</p></caption><graphic xlink:href="vetsci-11-00607-g009" position="float"/></fig><table-wrap position="float" id="vetsci-11-00607-t001"><object-id pub-id-type="pii">vetsci-11-00607-t001_Table 1</object-id><label>Table 1</label><caption><p>Primer sequences for PCR (F = forward, R = reverse).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Primer Sequences (5&#x02032;-3&#x02032;)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Accession Number</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;-actin</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F: CATCACCATCGGCAATGAGC<break/>R: AGCACCGTGTTGGCGTAGAG</td><td align="center" valign="middle" rowspan="1" colspan="1">NM_173979.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IL-1&#x003b2;</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F: GCTATGAGCCACTTCGTGAGGAC<break/>R: GATTGAGGGCGTCGTTCAGGAT</td><td align="center" valign="middle" rowspan="1" colspan="1">NM_174093.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IL-6</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F: TGATGACTTCTGCTTTCCCTACCC<break/>R: ATCTTTGCGTTCTTTACCCACTCG</td><td align="center" valign="middle" rowspan="1" colspan="1">NM_173923.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IL-8</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F: ATGACTTCCAAGCTGGCTGTT<break/>R: GGTTTAGGCAGACCTCGTTTC</td><td align="center" valign="middle" rowspan="1" colspan="1">NM_173925.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">TNF-&#x003b1;</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F: GCTCTCTCTCACATACCCTGC<break/>R: ATCCCGGATCATGCTTTTGGT</td><td align="center" valign="middle" rowspan="1" colspan="1">NM_173966.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">COX-2</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F: TCCTGAAACCCACTCCCAACA<break/>R: TGGGCAGTCATCAGGCACAG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AF_031698.1</td></tr></tbody></table></table-wrap></floats-group></article>